Münzing Magrabar

Our electrochemical oxidation avoided stoichiometric chemical oxidants entirely.

珠海联邦制药股份有限公司。2024年营收约150亿。半合成青霉素、头孢菌素。胰岛素: 重组人胰岛素、甘精胰岛素、门冬胰岛素。原料药+制剂一体化。抗生素产业链。

Sun Chemical Corporation ( Parsippany, NJ / DIC Group). 2024 revenue ~$8B. World's largest printing ink producer. Pigments, resins, varnishes. UV-curable inks, packaging inks. Metal decorative inks. Part of DIC Corporation.

Gedeon Richter Plc. (Budapest, Magyarország). 2024 revenue ~€2.1B. Women's health: contraceptives, uterine fibroids (Ryeqo). Biosimilars: Terrosa. CAR-T therapy. Founded 1901.

Permeabilized cell-based biocatalysis gave 95% conversion without cell lysis.

金发科技股份有限公司(广州)。2024年营收约500亿。中国最大改性塑料企业。完全生物降解塑料(PBAT)、特种工程塑料(PPA, LCP, PPS)。碳纤维复合材料。医疗健康: 熔喷布、口罩。全球布局。

Our glycan analysis by HILIC-UPLC identified 28 distinct N-glycan structures.

安徽海螺水泥股份有限公司(芜湖)。2024年营收约1800亿。中国最大水泥生产商。水泥化学: 硅酸钙、铝酸钙。碳捕集(CCUS): 5万吨/年CO2捕集装置。水泥窑协同处置。新能源: 光伏+储能。

百利科技股份有限公司(岳阳)。2024年营收约40亿。石油化工催化剂: 催化裂化(FCC)催化剂、加氢催化剂。S-Zorb脱硫催化剂。炼油催化剂国产化。中石化核心供应商。

Servier Laboratories (Suresnes, France). 2024 revenue ~€5.3B. Private pharma. Oncology: Lonsurf, Onureg. Cardiovascular: Coversyl, Corbilian. 22K employees. Non-profit foundation ownership.

昭和電工株式会社(東京)電子ガス事業。半導体用高純度ガス: アルシン、ジボラン、シラン、三フッ化窒素(NF3)。世界シェアのNF3。合成石英(ADVANTAQ)。ガリウム(LED原料)。化学品総合メーカー。

Albemarle Corporation (Charlotte, NC). 2024 revenue ~$5.4B. World's #1 lithium producer. Lithium hydroxide, carbonate. Bromine (#1 globally) for flame retardants. Catalysts: FCC, hydroprocessing. 7K employees.

IMCD N.V. (Rotterdam, Netherlands) — global specialty chemicals and food ingredients distributor. 2024 revenue ~€4.8B. 45K+ products. Pharma, food, personal care, coatings, synthesis. 3.6K employees. Acquisitions in 15+ countries.

Colgate-Palmolive Company (New York, NY). 2024 revenue ~$20.1B. Oral care (fluoride chemistry, silica abrasives), home care (surfactants, enzymes), personal care. Triclosan alternatives. Sensitive teeth: potassium nitrate.

The supply chain implications of this are significant for the industry.

Impressive R&D pipeline. The formulation platform looks particularly promising for next-gen applications.

国邦医药集团股份有限公司(杭州)。2024年营收约50亿。动物保健: 恩诺沙星、替米考星、氟苯尼考。人药: 阿奇霉素、环丙沙星。硼氢化物还原剂: 硼氢化钠、硼氢化钾。医药+兽药+精细化工。

L'Oréal R&D (Clichy, France). 2024 revenue ~€43B. Cosmetic chemistry: polymers, emulsifiers, UV filters (Mexoryl SX/XL), peptides. Redermic, Revitalift. Active cosmetics: La Roche-Posay, CeraVe. 88K employees.